Quotient Ltd (QTNT)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

28 ESPLANADE SAINT HELIER, JERSEY JE2 3QA

Quotient Ltd develops and manufactures transfusion diagnostic products. The company provides tests for blood grouping and serological disease screening, commonly referred to as transfusion diagnostics.

Data as of 2021-02-27 10:50:26 -0500
Market Cap454.088 Million Shares Outstanding101.133 Million Avg 30-day Volume1.189 Million
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-4.29 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.2234 52-week High/Low10.38 / 2.39 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from QTNT instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 101 110 -8.18% 38 (2.29%) 53 (3.3%) -28.3%
13F shares: 81.825 Million 81.359 Million 0.57% 49.6 Million 64.006 Million -22.51%
% Ownership 80.9978 80.5364 0.57% 49.0987 63.3591 -22.51%
New Positions: 13 27 -51.85% 3 18 -83.33%
Increased Positions 48 49 -2.04% 12 23 -47.83%
Closed Positions 20 12 66.67% 17 3 466.67%
Reduced Positions 29 20 45.0% 17 7 142.86%
Total Calls 167.189 Thousand 102.814 Thousand 62.61% 48.1 Thousand 14.1 Thousand 241.13%
Total Puts 95.531 Thousand 114.802 Thousand -16.79% 11 Thousand 15.5 Thousand -29.03%
PUT/CALL Ratio 0.57 1.12 -49.11% 0.23 1.1 -79.09%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding QTNT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding QTNT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

126 Thousand total shares from 2 transactions

Exercise Derivative Conversion (M)

167.7 Thousand total shares from 12 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WALT FRANZ CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
680,057 2021-02-24 12

BUHLER PETER CHIEF FINANCIAL OFFICER

  • Officer
26,667 2021-02-05 4

STACKAWITZ JEREMY CHIEF COMMERCIAL OFFICER

  • Officer
112,926 2021-02-04 4

FARRELL EDWARD CHIEF OPERATING OFFICER (+)

  • Officer
29,757 2021-02-03 5

WILKERSON L JOHN

  • Director
7,381,262 2021-01-31 4

HALLSWORTH FREDERICK

  • Director
109,057 2021-01-31 4

SHROFF ZUBEEN

  • Director
7,397,877 2021-01-31 5

MCDONOUGH BRIAN

  • Director
104,607 2021-01-31 4

VON PRONDZYNSKI HEINO

  • Director
268,919 2021-01-31 5

BUCKLE ISABELLE

  • Director
8,004 2021-01-31 4

LARUE CATHERINE

  • Director
8,004 2021-01-31 4

LARNACH ERNEST SEE REMARKS

  • Officer
9,066 2020-10-31 2

PERCEPTIVE ADVISORS LLC

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

EDELMAN JOSEPH

  • 10% Owner
16,200,818 2020-09-15 1

BOLOGNA THOMAS A

  • Director
185,046 2020-07-31 2

OCONNOR SARAH A

  • Director
58,063 2020-07-31 2

LINDOP CHRISTOPHER J EVP

  • Officer
376,647 2020-05-24 1

BOYD ROLAND SEE REMARKS

  • Officer
70,508 2019-08-19 0

GALEN PARTNERS V LP

GALEN PARTNERS INTERNATIONAL V LP

GALEN MANAGEMENT, LLC

GALEN PARTNERS V, L.L.C.

  • Director
  • 10% Owner
7,329,074 2018-07-23 0

COWAN D J PAUL E SEE REMARKS

  • Officer
  • Director
3,216,654 2017-10-30 0

COWAN DEIDRE

QUOTIENT BIODIAGNOSTICS GROUP LTD

  • 10% Owner
3,585,175 2016-08-03 0

UNGER STEPHEN CHIEF FINANCIAL OFFICER

  • Officer
0 2016-06-03 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

WALT FRANZ - Director - Officer CHIEF EXECUTIVE OFFICER

2021-02-24 16:05:25 -0500 2021-02-24 M 7,645 a 399,618 direct

WALT FRANZ - Director - Officer CHIEF EXECUTIVE OFFICER

2021-02-24 16:05:25 -0500 2021-02-24 M 7,645 d 22,936 direct

BUHLER PETER - Officer CHIEF FINANCIAL OFFICER

2021-02-08 16:05:26 -0500 2021-02-05 M 16,667 a 26,667 direct

BUHLER PETER - Officer CHIEF FINANCIAL OFFICER

2021-02-08 16:05:26 -0500 2021-02-05 M 16,667 d 33,333 direct

STACKAWITZ JEREMY - Officer CHIEF COMMERCIAL OFFICER

2021-02-08 16:05:16 -0500 2021-02-04 S 30,000 $5.14 d 112,926 direct

FARRELL EDWARD - Officer CHIEF OPERATING OFFICER (+)

2021-02-05 16:20:09 -0500 2021-02-03 M 96,000 a 125,757 direct

FARRELL EDWARD - Officer CHIEF OPERATING OFFICER (+)

2021-02-05 16:20:09 -0500 2021-02-03 M 96,000 d 0 direct

FARRELL EDWARD - Officer CHIEF OPERATING OFFICER (+)

2021-02-05 16:20:09 -0500 2021-02-03 S 96,000 $5.07 d 29,757 direct

WILKERSON L JOHN - Director

2021-02-02 16:05:25 -0500 2021-01-31 M 6,484 a 52,188 direct

SHROFF ZUBEEN - Director

2021-02-02 16:05:27 -0500 2021-01-31 M 7,528 a 68,803 direct

LARUE CATHERINE - Director

2021-02-02 16:05:23 -0500 2021-01-31 M 3,846 d 11,539 direct

BUCKLE ISABELLE - Director

2021-02-02 16:05:36 -0500 2021-01-31 M 3,846 a 8,004 direct

VON PRONDZYNSKI HEINO - Director

2021-02-02 16:05:42 -0500 2021-01-31 M 9,631 d 28,893 direct

WILKERSON L JOHN - Director

2021-02-02 16:05:25 -0500 2021-01-31 M 440 d 1,318 direct

SHROFF ZUBEEN - Director

2021-02-02 16:05:27 -0500 2021-01-31 M 1,484 d 4,450 direct

HALLSWORTH FREDERICK - Director

2021-02-02 16:05:31 -0500 2021-01-31 M 3,846 d 11,539 direct

LARUE CATHERINE - Director

2021-02-02 16:05:23 -0500 2021-01-31 M 3,846 a 8,004 direct

MCDONOUGH BRIAN - Director

2021-02-02 16:05:40 -0500 2021-01-31 M 3,846 d 11,539 direct

VON PRONDZYNSKI HEINO - Director

2021-02-02 16:05:42 -0500 2021-01-31 M 9,631 a 268,919 direct

WILKERSON L JOHN - Director

2021-02-02 16:05:25 -0500 2021-01-31 M 6,044 d 18,132 direct

SHROFF ZUBEEN - Director

2021-02-02 16:05:27 -0500 2021-01-31 M 6,044 d 18,132 direct

HALLSWORTH FREDERICK - Director

2021-02-02 16:05:31 -0500 2021-01-31 M 3,846 a 105,907 direct

BUCKLE ISABELLE - Director

2021-02-02 16:05:36 -0500 2021-01-31 M 3,846 d 11,539 direct

MCDONOUGH BRIAN - Director

2021-02-02 16:05:40 -0500 2021-01-31 M 3,846 a 51,567 direct

WALT FRANZ - Director - Officer CHIEF EXECUTIVE OFFICER

2021-01-25 16:05:13 -0500 2021-01-24 M 7,646 a 391,973 direct 0.6745 -16.6948 3.0354 3 -16.6948 6

WALT FRANZ - Director - Officer CHIEF EXECUTIVE OFFICER

2021-01-25 16:05:13 -0500 2021-01-24 M 7,646 d 30,581 direct

FARRELL EDWARD - Officer CHIEF OPERATING OFFICER (+)

2021-01-08 16:05:12 -0500 2021-01-07 M 744 a 29,757 direct 2.0761 7.2664 -19.7232 7.2664 6 -19.7232 31

FARRELL EDWARD - Officer CHIEF OPERATING OFFICER (+)

2021-01-08 16:05:12 -0500 2021-01-07 M 744 d 1,488 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
QUOTIENT LTD QTNT 2021-02-26 22:15:02 UTC -0.5763 0.6463 300000
QUOTIENT LTD QTNT 2021-02-26 21:45:03 UTC -0.5763 0.6463 300000
QUOTIENT LTD QTNT 2021-02-26 21:15:02 UTC -0.5763 0.6463 300000
QUOTIENT LTD QTNT 2021-02-26 20:45:03 UTC -0.5763 0.6463 300000
QUOTIENT LTD QTNT 2021-02-26 20:15:03 UTC -0.5763 0.6463 300000
QUOTIENT LTD QTNT 2021-02-26 19:45:03 UTC -0.5763 0.6463 300000
QUOTIENT LTD QTNT 2021-02-26 19:15:03 UTC -0.5763 0.6463 300000
QUOTIENT LTD QTNT 2021-02-26 18:45:03 UTC -0.5763 0.6463 300000
QUOTIENT LTD QTNT 2021-02-26 18:15:02 UTC -0.5763 0.6463 300000
QUOTIENT LTD QTNT 2021-02-26 17:45:02 UTC -0.5763 0.6463 300000
QUOTIENT LTD QTNT 2021-02-26 17:15:03 UTC -0.5763 0.6463 300000
QUOTIENT LTD QTNT 2021-02-26 16:45:03 UTC -0.5763 0.6463 300000
QUOTIENT LTD QTNT 2021-02-26 16:15:02 UTC -0.5763 0.6463 300000
QUOTIENT LTD QTNT 2021-02-26 15:45:03 UTC -0.5763 0.6463 300000
QUOTIENT LTD QTNT 2021-02-26 15:15:03 UTC -0.5763 0.6463 300000
QUOTIENT LTD QTNT 2021-02-26 14:45:03 UTC -0.5763 0.6463 300000
QUOTIENT LTD QTNT 2021-02-26 13:00:03 UTC -0.5763 0.6463 300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Advanced Series Trust- AST Academic Strategies Asset Allocation Portfolio QTNT -12300.0 shares, $-64083.0 2020-12-31 N-PORT

Elevate your investments